Journal
MEDICINA CLINICA
Volume 159, Issue 6, Pages 289-298Publisher
ELSEVIER ESPANA SLU
DOI: 10.1016/j.medcli.2022.04.004
Keywords
Autoimmune hepatitis; Acute autoimmune hepatitis; Drug-induced liver injury; Antibodies; Treatment
Categories
Ask authors/readers for more resources
Autoimmune hepatitis is a chronic liver disease characterized by liver inflammation, elevated transaminase and immunoglobulin G levels, autoantibodies, and inflammatory infiltrate in liver biopsy. The treatment involves the combination of corticoids and azathioprine, but some patients require second- or third-line therapies.
Autoimmune hepatitis is a chronic inflammatory disease of the liver. The etiology is partly unknown and commonly affects women of all ages. It is characterized by increase in transaminase and immuno-globulin G levels, autoantibodies, and portal inflammatory infiltrate with interface hepatitis in the liver biopsy. The treatment is based on the combination of corticoids and azathioprine, but 20-40% of patients require second-or third-line therapies due to intolerance or insufficient response. Here, we will revise the most important aspects regarding the diagnosis and treatment of autoimmune hepatitis emphasizing the challenges faced in clinical practice.(c) 2022 Elsevier Espana, S.L.U. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available